MedPath

Study for genetic susceptibility to pancreatic cancer

Not Applicable
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000016984
Lead Sponsor
Center for Clinical and Biomedical Research, Sapporo Higashi Tokushukai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Cases with neuroendocrine tumor

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Whole-exome sequencing using genomic DNA isolated from saliva, blood and the tissue
Secondary Outcome Measures
NameTimeMethod
Histopathological analysis and somatic mutation, gene expression and methylation analysis using the resected specimens
© Copyright 2025. All Rights Reserved by MedPath